TRIPS协定对药品专利及公共健康影响的经济行为分析  

Economic Analysis on Effects of TRIPS on the Conflict between Drug Patent Protection and Public Health

作　　者：徐君[1] 张继稳[2] 邵蓉[1] 

机构地区：[1]中国药科大学国际医药商学院,南京市210009 [2]中国科学院上海药物研究所,上海市201203

出　　处：《中国药房》2008年第31期2403-2405,共3页China Pharmacy

摘　　要：目的:探讨现行《与贸易有关的知识产权协定》(TRIPS)地域性保护的局限性,寻求药品专利权与公共健康权之间的平衡。方法:介绍TRIPS协定中对药品专利权与公共健康权保护的要求,并利用诺德豪斯模型方法对药品专利权与公共健康权相冲突的问题进行分析。结果:对药品专利提供最低水平保护的地域不能无限扩大。结论:应给予发展中国家优惠政策,在逐步加强药品专利保护的同时,保障人类最基本的健康权。OBJECTIVE： To discuss the limitation of the current TRIPS due to local protection and to seek for a balance between drug patent protection and public health. METHODS： The related clauses in TRIPS in terms of protection on drug patent and public health were introduced, and Nordhaus＇ model was used to analyze the conflict between drug patent protection and public health. RESULTS： The area with minimum level of drug patent protection can＇ t be enlarged infinitely geographically. CONCLUSIONS： Preferential policies should be given to the developing countries to secure the public health while strengthening the drug patent protection gradually.

关 键 词：药品 专利 与贸易有关的知识产权协定 公共健康 诺德豪斯模型 

分 类 号：R951[医药卫生—药学]